Back to GetFilings.com



 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 


 

FORM 10-Q

 


 

ý

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2003

 

or

 

o

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from             to            

 

Commission File Number: 0-30235

 


 

Exelixis, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

04-3257395

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

 

 

170 Harbor Way
P.O. Box 511
South San Francisco, CA 94083

(Address of principal executive offices, including zip code)

 

 

 

(650) 837-7000

(Registrant’s telephone number, including area code)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).  Yes ý No o

 

On October 31, 2003, there were 71,081,745 shares of common stock, par value $.001 per share, of Exelixis, Inc. outstanding.

 

 



 

EXELIXIS, INC.

 

QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2003

 

INDEX

 

Part I.  Financial Information

 

 

Item 1.

Unaudited Financial Statements

 

 

 

Consolidated Condensed Balance Sheets
September 30, 2003 and December 31, 2002

 

 

 

Consolidated Condensed Statements of Operations
Three and Nine Months Ended September 30, 2003 and 2002

 

 

 

Consolidated Condensed Statements of Cash Flows
Nine Months Ended September 30, 2003 and 2002

 

 

 

Notes to Consolidated Condensed Financial Statements

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

 

Item 4.

Controls and Procedures

 

 

Part II.  Other Information

 

 

Item 2.

Changes in Securities and Use of Proceeds

 

 

Item 5.

Other Information

 

 

Item 6.

Exhibits and Reports on Form 8-K

 

 

Signatures

 

2



 

PART I. FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

EXELIXIS, INC.
CONSOLIDATED CONDENSED BALANCE SHEETS
(in thousands)

 

 

 

September 30,
2003

 

December 31,
2002 (1)

 

 

 

(unaudited)

 

 

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

55,056

 

$

84,522

 

Short-term investments

 

144,627

 

131,704

 

Other receivables

 

2,844

 

3,325

 

Other current assets

 

4,834

 

3,841

 

Total current assets

 

207,361

 

223,392

 

 

 

 

 

 

 

Restricted cash

 

18,882

 

5,761

 

Property and equipment, net

 

34,622

 

32,406

 

Related-party receivables

 

540

 

904

 

Goodwill

 

67,364

 

67,364

 

Other intangibles, net

 

4,302

 

4,802

 

Other assets

 

3,753

 

4,484

 

Total assets

 

$

336,824

 

$

339,113

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

1,592

 

$

4,717

 

Other accrued expenses

 

9,675

 

7,992

 

Accrued compensation and benefits

 

5,743

 

5,060

 

Current portion of capital lease obligations

 

5,552

 

6,840

 

Current portion of notes payable and bank obligations

 

4,658

 

1,840

 

Deferred revenue

 

17,267

 

23,790

 

Total current liabilities

 

44,487

 

50,239

 

 

 

 

 

 

 

Capital lease obligations

 

2,467

 

6,280

 

Notes payable and bank obligations

 

11,834

 

3,973

 

Convertible promissory note and loan

 

55,000

 

55,000

 

Other long-term liabilities

 

869

 

119

 

Deferred revenue

 

38,716

 

47,582

 

Total liabilities

 

153,373

 

163,193

 

 

 

 

 

 

 

Commitments

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock

 

 

 

Common stock

 

72

 

59

 

Additional paid-in-capital

 

541,276

 

463,764

 

Notes receivable from stockholders

 

(475

)

(1,210

)

Deferred stock compensation, net

 

(136

)

(977

)

Accumulated other comprehensive income

 

1,563

 

1,638

 

Accumulated deficit

 

(358,849

)

(287,354

)

Total stockholders’ equity

 

183,451

 

175,920

 

 

 

 

 

 

 

Total liabilities and stockholders’ equity

 

$

336,824

 

$

339,113

 

 


(1) The consolidated condensed balance sheet at December 31, 2002 has been derived from the audited financial statement at that date but does not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

 

The accompanying notes are an integral part of these consolidated condensed financial statements.

 

3



 

EXELIXIS, INC.
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

 

2003

 

2002

 

2003

 

2002

 

 

 

 

 

 

 

 

 

 

 

Revenues:

 

 

 

 

 

 

 

 

 

Contract and government grants

 

$

9,310

 

$

8,449

 

$

28,389

 

$

25,268

 

License

 

3,129

 

1,981

 

9,385

 

6,601

 

Total revenues

 

12,439

 

10,430

 

37,774

 

31,869